Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 2913-2922

  Taxt, Arne M ^a   Diaz, Yuleima ^a   Bacle, Amélie ^b   Grauffel, Cédric ^b   Reuter, Nathalie ^a,b   Aasland, Rein ^a   Sommerfelt, Halvor ^a,c   Puntervoll, Pål ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b Uni Research AS   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; DISULFIDE; EPITOPE; GUANYLIN; HUMAN HEAT STABLE TOXIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PORCINE HEAT STABLE TOXIN; UNCLASSIFIED DRUG; UROGUANYLIN;

AMINO ACID SEQUENCE; ARTICLE; CONJUGATION; CROSS REACTION; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL TOXINS; CLONING, MOLECULAR; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; GASTROINTESTINAL HORMONES; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MODELS, MOLECULAR; NATRIURETIC PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 84903219903     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01749-14     Document Type: Article

References (51)

1. Walker RI, Steele D, Aguado T. 2007. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease. Vaccine 25:2545-2566. http://dx.doi.org/10.1016/j.vaccine.2006.12.028.
2. Taxt A, Aasland R, Sommerfelt H, Nataro J, Puntervoll P. 2010. Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect. Immun. 78:1824-1831. http://dx.doi.org/10.1128/IAI.01397-09.
3. Liu M, Ruan X, Zhang C, Lawson SR, Knudsen DE, Nataro JP, Robertson DC, Zhang W. 2011. Heat-labile-and heat-stable-toxoid fusions (LTR192G-STaP13F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies. Infect. Immun. 79:4002-4009. http://dx.doi.org/10.1128/IAI.00165-11.
4. Zhang W, Zhang C, Francis DH, Fang Y, Knudsen D, Nataro JP, Robertson DC. 2010. Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies. Infect. Immun. 78:316-325. http://dx.doi.org/10.1128/IAI.00497-09.
5. Zeng W, Azzopardi K, Hocking D, Wong CY, Robevska G, Tauschek M, Robins-Browne RM, Jackson DC. 2012. A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli. Vaccine 30:4800-4806. http://dx.doi.org/10.1016/j.vaccine.2012.05.017.
6. Deng G, Zeng J, Jian M, Liu W, Zhang Z, Liu X, Wang Y. 2013. Nanoparticulated heat-stable (STa) and heat-labile B subunit (LTB) recombinant toxin improves vaccine protection against enterotoxigenic Escherichia coli challenge in mouse. J. Biosci. Bioeng. 115:147-153. http://dx.doi.org/10.1016/j.jbiosc.2012.09.009.
7. Ruan X, Robertson DC, Nataro JP, Clements JD, Zhang W. 2014. Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to a double mutant heat-labile toxin peptide in inducing neutralizing anti-STa antibodies. Infect. Immun. 82:1823-1832. http://dx.doi.org/10.1128/IAI.01394-13.
8. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acácio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
9. Wolf MK. 1997. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin. Microbiol. Rev. 10:569-584.
10. Steinsland H, Valentiner-Branth P, Perch M, Dias F, Fischer TK, Aaby P, Mølbak K, Sommerfelt H. 2002. Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. J. Infect. Dis. 186:1740-1747. http://dx.doi.org/10.1086/345817.
11. Lockwood DE, Robertson DC. 1984. Development of a competitive enzyme-linked immunosorbent assay (ELISA) for Escherichia coli heatstable enterotoxin (STa). J. Immunol. Methods 75:295-307. http://dx.doi.org/10.1016/0022-1759(84)90113-3.
12. Takeda T. 1983. Neutralization of activity of two different heat-stable enterotoxins (STh and STp) of enterotoxigenic Escherichia coli by homologous and heterologous antisera. FEMS Microbiol. Lett. 20:357-359. http://dx.doi.org/10.1111/j.1574-6968.1983.tb00147.x.
13. Aref N-EM, Saeed AM. 2011. Design and characterization of highly immunogenic heat-stable enterotoxin of enterotoxigenic Escherichia coli K99(+). J. Immunol. Methods 366:100-105. http://dx.doi.org/10.1016/j.jim.2011.01.012.
14. Kennedy DJ, Greenberg RN, Dunn JA, Abernathy R, Ryerse JS, Guerrant RL. 1984. Effects of Escherichia coli heat-stable enterotoxin STb on intestines of mice, rats, rabbits, and piglets. Infect. Immun. 46:639-643.
15. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140. http://dx.doi.org/10.1038/nrmicro818.
16. Forte LR. 2004. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol. Ther. 104:137-162. http://dx.doi.org/10.1016/j.pharmthera.2004.08.007.
17. Hamra FK, Forte LR, Eber SL, Pidhorodeckyj NV, Krause WJ, Freeman RH, Chin DT, Tompkins JA, Fok KF, Smith CE, Duffin KL, Siegel NR, Currie MG. 1993. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 90:10464-10468. http://dx.doi.org/10.1073/pnas.90.22.10464.
18. Ozaki H, Sato T, Kubota H, Hata Y, Katsube Y, Shimonishi Y. 1991. Molecular structure of the toxin domain of heat-stable enterotoxin produced by a pathogenic strain of Escherichia coli.Aputative binding site for a binding protein on rat intestinal epithelial cell membranes. J. Biol. Chem. 266:5934-5941.
19. Marx UC, Klodt J, Meyer M, Gerlach H, Rösch P, Forssmann WG, Adermann K. 1998. One peptide, two topologies: structure and interconversion dynamics of human uroguanylin isomers. J. Pept. Res. 52:229-240.
20. Skelton NJ, Garcia KC, Goeddel DV, Quan C, Burnier JP. 1994. Determination of the solution structure of the peptide hormone guanylin: observation of a novel form of topological stereoisomerism. Biochemistry 33:13581-13592. http://dx.doi.org/10.1021/bi00250a010.
21. Schulz A, Marx UC, Tidten N, Lauber T, Hidaka Y, Adermann K. 2005. Side chain contributions to the interconversion of the topological isomers of guanylin-like peptides. J. Pept. Sci. 11:319-330. http://dx.doi.org/10.1002/psc.625.
22. Nakazato M. 2001. Guanylin family: new intestinal peptides regulating electrolyte and water homeostasis. J. Gastroenterol. 36:219-225. http://dx.doi.org/10.1007/s005350170106.
23. Sindić A, Schlatter E. 2006. Cellular effects of guanylin and uroguanylin. J. Am. Soc. Nephrol. 17:607-616. http://dx.doi.org/10.1681/ASN.2005080818.
24. Nakazato M, Yamaguchi H, Kinoshita H, Kangawa K, Matsuo H, Chino N, Matsukura S. 1996. Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency. Biochem. Biophys. Res. Commun. 220:586-593. http://dx.doi.org/10.1006/bbrc.1996.0447.
25. Moss NG, Fellner RC, Qian X, Yu SJ, Li Z, Nakazato M, Goy MF. 2008. Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide. Endocrinology 149:4486-4498. http://dx.doi.org/10.1210/en.2007-1725.
26. Qian X, Moss NG, Fellner RC, Goy MF. 2008. Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules. Endocrinology 149:4499-4509. http://dx.doi.org/10.1210/en.2007-1724.
27. Jaleel M. 2002. Expression of the receptor guanylyl cyclase C and its ligands in reproductive tissues of the rat: a potential role for a novel signaling pathway in the epididymis. Biol. Reprod. 67:1975-1980. http://dx.doi.org/10.1095/biolreprod.102.006445.
28. Gong R, Ding C, Hu J, Lu Y, Liu F, Mann E, Xu F, Cohen MB, Luo M. 2011. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 333:1642-1646. http://dx.doi.org/10.1126/science.1207675.
29. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA. 1979. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am. J. Epidemiol. 110:105-123.
30. Safranek TJ, Lawrence DN, Kurland LT, Culver DH, Wiederholt WC, Hayner NS, Osterholm MT, O'Brien P, Hughes JM. 1991. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Am. J. Epidemiol. 133:940-951.
31. Jonville-Béra AP, Autret E, Galy-Eyraud C, Hessel L. 1996. Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French Regional Pharmacovigilance Centres and Pasteur-Mérieux Sérums et Vaccins. Pediatr. Infect. Dis. J. 15:44-48. http://dx.doi.org/10.1097/00006454-199601000-00010.
32. Beeler J, Varricchio F, Wise R. 1996. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr. Infect. Dis. J. 15:88-90. http://dx.doi.org/10.1097/00006454-199601000-00020.
33. Massell BF, Honikman LH, Amezcua J. 1969. Rheumatic fever following streptococcal vaccination. Report of three cases. JAMA 207:1115-1119.
34. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB. 2005. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41: 1114-1122. http://dx.doi.org/10.1086/444458.
35. WHO. 2005. Group A streptococcal vaccine development: current status and issues of relevance to less developed countries. WHO, Geneva, Switzerland.
36. Martin S, Adermann K, Forssmann WG, Kuhn M. 1999. Regulated, sidedirected secretion of proguanylin from isolated rat colonic mucosa. Endocrinology 140:5022-5029. http://dx.doi.org/10.1210/endo.140.11.7103.
37. Garrett BM, Visweswariah SS. 1996. A conformational epitope in the N-terminus of the Escherichia coli heat-stable enterotoxins is involved in receptor-ligand interactions. Biochim. Biophys. Acta 1317:149-154. http://dx.doi.org/10.1016/S0925-4439(96)00047-6.
38. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen M, Pieper U, Sali A. 2006. Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics Chapter 5:Unit 5.6. http://dx.doi.org/10.1002/0471250953.bi0506s15.
39. Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. 2009. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30:1545-1614. http://dx.doi.org/10.1002/jcc.21287.
40. Kalé L, Skeel RD, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips JC, Shinozaki A, Varadarajan K, Schulten K. 1999. NAMD2: greater scalability for parallel molecular dynamics. J. Comput. Phys. 151: 283-312. http://dx.doi.org/10.1006/jcph.1999.6201.
41. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L, Schulten K. 2005. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26:1781-1802. http://dx.doi.org/10.1002/jcc.20289.
42. MacKerell AD, Jr, Bashford D, Bellott M, Dunbrack RL, Jr, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiórkiewicz-Kuczera J, Yin D, Karplus M. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102:3586-3616. http://dx.doi.org/10.1021/jp973084f.
43. Mackerell AD, Feig M, Brooks CL. 2004. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J. Comput. Chem. 25:1400-1415. http://dx.doi.org/10.1002/jcc.20065.
44. Jo S, Kim T, Iyer VG, Im W. 2008. CHARMM-GUI: a Web-based graphical user interface for CHARMM. J. Comput. Chem. 29:1859-1865. http://dx.doi.org/10.1002/jcc.20945.
45. Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P. 1999. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34:105-116.
46. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850-858. http://dx.doi.org/10.1021/ac950914h.
47. Zhang W, Robertson DC, Zhang C, Bai W, Zhao M, Francis DH. 2008. Escherichia coli constructs expressing human or porcine enterotoxins induce identical diarrheal diseases in a piglet infection model. Appl. Environ. Microbiol. 74:5832-5837. http://dx.doi.org/10.1128/AEM.00893-08.
48. Lauber T, Neudecker P, Rösch P, Marx UC. 2003. Solution structure of human proguanylin: the role of a hormone prosequence. J. Biol. Chem. 278:24118-24124. http://dx.doi.org/10.1074/jbc.M300370200.
49. Ragvin A, Valvatne H, Erdal S, Arskog V, Tufteland KR, Breen K, Øyan AM, Eberharter A, Gibson TJ, Becker PB, Aasland R. 2004. Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300. J. Mol. Biol. 337:773-788. http://dx.doi.org/10.1016/j.jmb.2004.01.051.
50. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, Wiley CJ, Allison RD, Bittner M, Blackshaw S (ed). 2003. Current protocols in molecular biology. John Wiley & Sons, Inc, New York, NY.
51. Ritz C, Streibig JC. 2005. Bioassay analysis using R. J. Stat. Softw. 12(5): 1-22. http://www.jstatsoft.org/v12/i05/paper.